| October 2003 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
| Sep Nov | ||||||
For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.
C H A N N E L S
• PULSE Home
Page
•
EXECUTIVE
EDITION
•
US News
•
Canada
News
•
UK News
•
New
Zealand News
•
Consumer
Advocacy
•
Health
Care Systems
•
Managed
Care/Medicaid
•
Co-occurring
Disorders
•
Clinical
studies
•
Pharmaceutical
News
•
Criminal
Justice Systems
•
Legislative
News
U S E R ' S G
U I D E
About
PULSE
PULSE Channels
Archives
Adding comments
Using the # link
Items that require registration
PULSE syndication
Tips for Searching PULSE
E M A I L S
U B S C R I P T I O N S
For WEEKLY summaries
of PULSE postings, see the weekly
email subscription form.
For DAILY mailings (powered
by Bloglet), please enter your e-mail address below:
PULSE ANNUAL No. 2
January 2003
Recent
Trends, Challenges and Issues in Funding Public Mental Health Services
in the US
March 2002
PULSE ANNUAL No. 1
October 2001
PULSE is powered by
Radio Userland.
© Bill Davis, 2000-2003.
![]()
Antidepressants Seem to Have Reduced Teen Suicides
Reuters Health story at Yahoo - "In the last decade, a fall in adolescent suicide rates in the U.S. has coincided with an increase in the use of drugs to treat depression. Now, new study findings strengthen this association by showing that these changes often occurred in the same geographical regions. ... The current findings, which are reported in the Archives of General Psychiatry, are based on a study of antidepressant use and suicide rates among teens in 588 U.S. postal codes during the 1990s. The researchers analyzed data from several sources, including a major pharmacy benefit program, national suicide mortality files, and the U.S. census."
Controversial Implant Sparks 'Town Hall'
Newsday story - "Scientists at the University of Pennsylvania are developing a controversial implant designed to deliver small doses of antipsychotic medicines for up to a year to people with schizophrenia. Knowing that this approach raises a host of medical and ethical issues, the researchers held a medical 'town hall' meeting last month."![]()